Yuflyma
adalimumab-aaty · KIT · CELLTRION USA, Inc.
No Recall History
Plain English
Yuflyma is a kit containing adalimumab-aaty. Manufactured by CELLTRION USA, Inc..
Key Facts
- Brand Name
- Yuflyma
- Generic Name
- adalimumab-aaty
- NDC Code (Product)
72606-063- Manufacturer
- CELLTRION USA, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA761219
- Marketing Start
- 10/31/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
intentional dose omission570 reports
death211 reports
drug ineffective198 reports
intentional product use issue192 reports
device malfunction139 reports
arthralgia124 reports
exposure via skin contact121 reports
fatigue120 reports
therapy interrupted120 reports
accidental exposure to product119 reports
Frequently Asked Questions
What is Yuflyma used for?
Yuflyma contains adalimumab-aaty. It is a kit taken as directed. Consult your doctor for specific uses.
Is Yuflyma a controlled substance?
Yuflyma is not classified as a controlled substance by the DEA.
What is the generic name for Yuflyma?
The generic name for Yuflyma is adalimumab-aaty. There are 3 other brand versions of adalimumab-aaty.
What is the NDC code for Yuflyma ?
The NDC (National Drug Code) for Yuflyma is 72606-063, listed by CELLTRION USA, Inc..